ES2556460T3 - Derivados novedosos de metilciclohexano y usos de los mismos - Google Patents
Derivados novedosos de metilciclohexano y usos de los mismos Download PDFInfo
- Publication number
- ES2556460T3 ES2556460T3 ES11829552.6T ES11829552T ES2556460T3 ES 2556460 T3 ES2556460 T3 ES 2556460T3 ES 11829552 T ES11829552 T ES 11829552T ES 2556460 T3 ES2556460 T3 ES 2556460T3
- Authority
- ES
- Spain
- Prior art keywords
- pyridin
- carboxylic acid
- methylcyclohexane
- synthesis
- nmr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/53—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/205—Radicals derived from carbonic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Reproductive Health (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Un compuesto seleccionado del grupo que consiste en un derivado de metilciclohexano representado por la Fórmula I siguiente y una sal, un solvato y un hidrato del derivado de metilciclohexano farmacéuticamente aceptables y una combinación de los mismos.**Fórmula** en la que Ar se selecciona entre el grupo que consiste en fenilo, piridina y piridin-N-óxido, cada uno de los cuales está sustituido con uno o más sustituyentes idénticos o diferentes seleccionados del grupo que consiste en un átomo de hidrógeno, un alquilo C1 a C6 lineal o ramificado, halógeno, un alcoxi C1 a C6 lineal o ramificado y trifluorometilo; X es O, (C>=O)O, NR1(C>=O)O, NH, (C>=O)NH o O(C>=O)NH y R1 es H o CH3; Y es CH2, O o N-R2; R2 es H o CH3; A es O o NH; B es CH o N; y m es un número entero entre 0 y 2 y n es 0 o 1.
Description
(m, 3H), 3,91 (s, 2H), 3,40~3,23 (m, 4H), 3,01~2,91 (m, 3H), 2,11~1,51 (m, 9H), 1,42~1,05 (m, 4H)
Ejemplo 11: Síntesis del éster 4-(1-oxi-piridin-4-ilmetilcarbamoiloxi)-ciclohexilmetílico del ácido pirrolidin-1carboxílico
Un compuesto objetivo (393 mg, 52 % de rendimiento) se obtuvo de la misma manera que en el Ejemplo 1, excepto que se utilizó como material de partida C-(1-oxi-piridin-4-il)metilamina.
10 RMN de 1H (500 MHz, CDCl3), ppm (δ): 8,14-8,13 (d, 2H, J = 6,3 Hz), 7,29-7,21 (d, 2H, J = 6,3 Hz), 5,95 (s, 1H), 4,58-4,52 (m, 1H) , 3,91-3,85 (m, 2H), 3,36-3,30 (m, 5H), 3,00-2,50 (m, 1H), 2,0 (m, 2H), 1,83-1,82 (m, 7H), 1,591,53 (m, 2H), 1,31-1,21 (m, 4H), 1,14-1,3 (m, 2H)
15 Ejemplo 12: Síntesis del éster 4-(1-oxi-piridin-3-ilmetilcarbamoiloxi)-ciclohexilmetílico del ácido pirrolidin-1carboxílico
20 Un compuesto objetivo (325 mg, 43 % de rendimiento) se obtuvo de la misma manera que en el Ejemplo 1, excepto que se utilizó como material de partida C-(1-oxi-piridin-3-il)-metilamina.
RMN de 1H (500 MHz, CDCl3), ppm (δ): 8,21-8,13 (m, 1H), 7,26-7,24 (m, 3H), 5,16-4,59 (m, 1H), 4,35 (m, 1H), 3,923,91 (m, 1H), 3,41-3,33 (m, 2H), 2,8-2,4 (m, 1H), 1,87-1,84 (m, 4H), 1,63 (m, 4H), 1,35-1,11 (m, 2H)
25 Ejemplo 13: Síntesis del éster 4-(1-oxi-piridin-2-ilmetilcarbamoiloxi)-ciclohexilmetílico del ácido pirrolidin-1carboxílico
Un compuesto objetivo (264 mg, 35 % de rendimiento) se obtuvo de la misma manera que en el Ejemplo 1, excepto que se utilizó como material de partida C-(1-oxi-piridin-2-il)metilamina.
14
RMN de 1H (500 MHz, CDCl3), ppm (δ): 8,29-8,19 (d, 1H, J = 6,3 Hz), 7,38-7,37 (m, 1H), 7,25-7,18 (m, 2H), 6,236,21 (m, 1H), 4,48-4,45 (m, 3H), 3,85-3,82 (m, 2H), 3,32-3,25 (m, 4H), 1,97-1,93 (m, 2H), 1,81-1,74 (m, 6H), 1,581,82 (m , 2H), 1,27-1,20 (m, 4H)
Ejemplo 14: Síntesis del éster 4-(6-cloro-piridin-2-ilmetilcarbamoiloxi)-ciclohexilmetílico del ácido pirrolidin1-carboxílico
10 Un compuesto objetivo (491 mg, 62 % de rendimiento) se obtuvo de la misma manera que en el Ejemplo 1, excepto que se utilizó como material de partida C-(6-cloro-piridin-2-il)metilamina.
RMN de 1H (300 MHz, CDCl3), ppm (δ): 7,67~7,60 (m, 1H), 7,26~7,21 (m, 2H), 5,61~5,55 (m, 1H), 4,64~4,53 (m, 1H), 4,44 (d, 2H, J = 5,7 Hz), 3,90 (d, 2H, J = 6,0 Hz), 3,42~3,28 (m, 4H), 2,10~1,99 (m, 2H), 1,92~1,84 (m, 5H), 15 1,67~1,55 (m, 2H), 1,40~1,03 (m, 4H)
Ejemplo 15: Síntesis del éster 4-(6-metil-piridin-2-ilmetilcarbamoiloxi)-ciclohexilmetílico del ácido pirrolidin-1ácido carboxílico
Un compuesto objetivo (451 mg, 60 % de rendimiento) se obtuvo de la misma manera que en el Ejemplo 1, excepto que se utilizó como material de partida C-(6-metil-piridin-2-il)metilamina.
25 RMN de 1H (300 MHz, CDCl3), ppm (δ): 7,58~7,50 (m, 1H), 7,10~7,01 (m, 2H), 5,84~5,79 (m, 1H), 4,65~4,55 (m, 1H), 4,44 (d, 2H, J = 5,1 Hz), 3,90 (d, 2H, J = 6,3 Hz), 3,42~3,10 (m, 4H), 2,53 (s, 3H), 2,15~1,99 (m, 2H), 1,95~1,75 (m, 5H), 1,73~1,52 (m, 2H), 1,44~1,03 (m, 4H)
Ejemplo 16: Síntesis del éster 4-(2-cloro-piridin-4-ilmetilcarbamoiloxi)-ciclohexilmetílico del ácido pirrolidin30 1-carboxílico
Un compuesto objetivo (523 mg, 66 % de rendimiento) se obtuvo de la misma manera que en el Ejemplo 1, excepto que se utilizó como material de partida C-(2-cloro-piridin-4-il)metilamina.
15
RMN de 1H (300 MHz, CDCl3), ppm (δ): 8,33 (d, 1H, J = 5,1 Hz), 7,25 (s, 1H), 7,14 (d, 1H, J = 4,8 Hz), 5,33~5,26 (m, 1H), 4,65~4,54 (m, 1H), 4,36 (d, 2H, J = 6,3 Hz), 3,90 (d, 2H, J = 6,3 Hz), 3,41~3,29 (m, 4H), 2,18~1,99 (m, 2H), 1,95~1,77 (m, 6H), 1,70~1,52 (m, 1H), 1,43~1,03 (m, 4H)
Ejemplo 17: Síntesis del éster 4-(6-cloro-piridin-3-ilmetilcarbamoiloxi)-ciclohexilmetílico del ácido pirrolidin1-carboxílico
10 Un compuesto objetivo (435 mg, 55 % de rendimiento) se obtuvo de la misma manera que en el Ejemplo 1, excepto que se utilizó como material de partida C-(6-cloro-piridin-3-il)-metilamina.
RMN de 1H (300 MHz, CDCl3), ppm (~): 8,31 (s, 1H), 7,63 (d, 1H, J = 7,2 Hz), 7,30 (d, 1H, J = 8,4 Hz), 5,20~5,12 (m, 1H), 4,63~4,52 (m, 1H), 4,34 (d, 2H, J = 6,0 Hz), 3,90 (d, 2H, J = 6,6 Hz), 3,41~3,28 (m, 4H), 2,13~1,99 (m, 2H), 15 1,97~1,72 (m, 6H), 1,69~1,53 (m, 1H), 1,42~1,04 (m, 4H)
Ejemplo 18: Síntesis del éster 4-(2-cloro-piridin-3-ilmetilcarbamoiloxi)-ciclohexilmetílico del ácido pirrolidin1-carboxílico
Un compuesto objetivo (404 mg, 51 % de rendimiento) se obtuvo de la misma manera que en el Ejemplo 1, excepto que se utilizó como material de partida C-(2-cloro-piridin-3-il)-metilamina.
25 RMN de 1H (300 MHz, CDCl3), ppm (δ): 8,34~8,28 (m, 1H), 7,75 (d, 1H, J = 6,6 Hz), 7,27~7,21 (m, 1H), 5,35~5,27 (m, 1H), 4,62~4,50 ( m, 1H), 4,42 (d, 2H, J = 6,6 Hz), 3,90 (d, 2H, J = 6,3 Hz), 3,42~3,28 (m, 4H), 2,15~1,77 (m, 8H), 1,74~1,50 (m, 1H), 1,46~1,02 (m, 4H)
Ejemplo 19: Síntesis del éster del 4-(6-trifluorometil-piridin-3-ilmetilcarbamoiloxi)-ciclohexilmetílico del ácido 30 pirrolidin-1-carboxílico
16
Ejemplo 29: Síntesis del éster 4-bencilcarbamoiloxi-ciclohexilmetílico del ácido 4-metil-piperazin-1carboxílico
5 Un compuesto objetivo (101 mg, 13 % de rendimiento) se obtuvo de la misma manera que en el Ejemplo 1, excepto que fueron utilizados como materiales de partida bencilamina y 1-metil-piperazina y el yoduro de metilo no se utilizó en el segundo paso.
10 RMN de 1H (500 MHz, CDCl3), ppm (δ): 7,38~7,24 (m, 5H), 4,96 (sa, 1H), 4,65~4,54 (m, 1H), 3,92 (d, 2H, J = 6,4 Hz), 3,51~3,47 (m, 4H), 2,41~2,34 (m, 4H), 2,30 (s, 3H), 2,12~2,02 (m, 1H), 1,94~1,79 (m, 2H), 1,68~1,52 (m, 2H), 1,38~1,29 ( m, 2H), 1,20~1,09 (m, 2H)
15
A una solución de éster 4-hidroxi-ciclohexilmetílico del ácido pirrolidin-1-carboxílico (1 mmol) en cloruro de metileno (5 ml) se añadieron cloruro de picolinoílo (1,1 mmol) y trietilamina (1,5 mmol) y la mezcla resultante se agitó durante
20 16 horas a temperatura ambiente. La mezcla de reacción se diluyó con agua, seguido de par de veces de extracción con cloruro de metileno. La capa orgánica combinada se secó sobre sulfato de magnesio anhidro, se filtró y se concentró a presión reducida. El residuo se purificó por cromatografía en columna (gel de sílice, acetato de etilo), completando de este modo la preparación de un compuesto objetivo (233 mg, rendimiento del 70 %).
25 RMN del 1H (300 MHz, CDCl3), ppm (δ): 8,80~8,76 (m, 1H), 8,15~8,11 (m, 1H), 7,90~7,80 (m, 1H), 7,50~7,45 (m, 1H), 5,08~4,98 (m, 1H ), 3,98 (d, 2H, J = 6,6 Hz), 3,43~3,33 (m, 4H), 2,17~2,08 (m, 2H), 1,99~1,83 (m, 5H), 1,81~1,53 (m, 3H), 1,20~1,08 (m, 3H)
Los Ejemplos 31 a 33 siguientes se llevan a cabo cada uno de la misma manera que en el Ejemplo 30, excepto que 30 el material de partida utilizado era diferente del material de partida utilizado en el Ejemplo 30.
20
- Ejemplo 13
- 27,9 >50
- Ejemplo 14
- 21,7 22,3
- Ejemplo 15
- 19,9 19,4
- Ejemplo 16
- 27,9 10,8
- Ejemplo 17
- 29,5 12,5
- Ejemplo 18
- 5,7 18,3
- Ejemplo 19
- 11,1 13,8
- Ejemplo 20
- 50 37,9
- Ejemplo 21
- 15,9 44,8
- Ejemplo 22
- 35,8 21,7
- Ejemplo 23
- 28,6 >50
- Ejemplo 24
- >50 >50
- Ejemplo 25
- 24,9 15,5
- Ejemplo 26
- 46,1 36,8
- Ejemplo 27
- 50,0 >50
- Ejemplo 28
- >50 44,8
- Ejemplo 29
- 46,1 >50
- Ejemplo 30
- >50 >50
- Ejemplo 31
- >50 21,1
- Ejemplo 32
- 21,1 34,8
- Ejemplo 33
- >50 >50
- Ejemplo 34
- 24,9 27,1
- Ejemplo 35
- >50 50,0
- Ejemplo 36
- >50 >50
- Ejemplo 37
- 46,1 >50
- Ejemplo 38
- 35,8 >50
- Ejemplo 39
- >50 >50
- Ejemplo 40
- >50 >50
- Ejemplo 41
- 50 >50
- Ejemplo 42
- 50 >50
- Ejemplo 43
- 10,5 12,0
- Ejemplo 44
- 21,7 16,8
- Ejemplo 45
- 9,9 7,5
- Ejemplo 46
- 32,0 26,3
- Ejemplo 47
- 13,1 21,1
- Ejemplo 48
- 13,5 10,2
- Ejemplo 49
- 12,0 10,2
- Ejemplo 50
- 5,7 14,2
- Ejemplo 51
- 50 >50
- Ejemplo 52
- 22,3 >50
- Ejemplo 53
- 33,9 >50
- Ejemplo 54
- 48,7 >50
- Ejemplo 55
- 25,6 >50
Ejemplo 57: Prueba de alivio del dolor utilizando un modelo animal
1) Modelo animal 5 Se adquirieron as ratas macho (Sprague-Dawley, 150-200 g, de 6 semanas de edad, Orient Bio Co., Ltd) y se aclimataron en una cámara de animales durante una semana. La cámara de animales se encendía y apagaba alternativamente a intervalos de 12 horas, con una temperatura de 22 a 25 ºC y una humedad relativa de 40-60 % y se suministró agua y alimento ad libitum a las ratas. 10
31
Claims (1)
-
imagen1 imagen2 imagen3 imagen4
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20100094463 | 2010-09-29 | ||
KR20100094463 | 2010-09-29 | ||
PCT/KR2011/007117 WO2012044046A2 (en) | 2010-09-29 | 2011-09-28 | Novel methylcyclohexane derivatives and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2556460T3 true ES2556460T3 (es) | 2016-01-18 |
Family
ID=45893639
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES11829552.6T Active ES2556460T3 (es) | 2010-09-29 | 2011-09-28 | Derivados novedosos de metilciclohexano y usos de los mismos |
Country Status (14)
Country | Link |
---|---|
US (1) | US8822463B2 (es) |
EP (1) | EP2621899B1 (es) |
JP (1) | JP5921555B2 (es) |
KR (1) | KR101803955B1 (es) |
CN (1) | CN103237790B (es) |
AU (1) | AU2011308174A1 (es) |
BR (1) | BR112013005873A2 (es) |
CA (1) | CA2813189C (es) |
CL (1) | CL2013000835A1 (es) |
ES (1) | ES2556460T3 (es) |
MX (1) | MX2013003389A (es) |
RU (1) | RU2013114767A (es) |
WO (1) | WO2012044046A2 (es) |
ZA (1) | ZA201301674B (es) |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3153015B2 (ja) | 1992-09-07 | 2001-04-03 | サントリー株式会社 | 4−(アミノメチル)シクロヘキサンカルボキサミド誘導体 |
GB0030710D0 (en) * | 2000-12-15 | 2001-01-31 | Hoffmann La Roche | Piperazine derivatives |
US6802897B1 (en) * | 2002-05-31 | 2004-10-12 | Marathon Ashland Petroleum Llc | Biodiesel sulfur slurry |
FR2842885B1 (fr) * | 2002-07-24 | 2004-09-10 | Inst Francais Du Petrole | Procede de transport des petroles bruts lourds sous forme de dispersion |
AU2004258751C1 (en) | 2003-07-28 | 2008-07-17 | Merz Pharma Gmbh & Co. Kgaa | The use of 1-amino-alkylcyclohexane compounds in the treatment of pain hypersensitivity |
EP1778652A2 (en) | 2004-08-20 | 2007-05-02 | EntreMed, Inc. | Compositions and methods comprising proteinase activated receptor antagonists |
FR2878937B1 (fr) * | 2004-12-07 | 2007-02-09 | Inst Francais Du Petrole | Methode de traitement d'un hydrocarbure visqueux par inertage in situ des asphaltenes |
PL1883451T3 (pl) * | 2005-04-13 | 2011-05-31 | Neuraxon Inc | Podstawione związki indolowe mające aktywność hamowania NOS |
TW200938203A (en) * | 2007-12-17 | 2009-09-16 | Intervet Int Bv | Anthelmintic agents and their use |
EP2240020A4 (en) | 2008-01-09 | 2011-05-11 | Trovis Pharmaceuticals Llc | INTRATHEAL TREATMENT OF NEUROPATHIC PAIN WITH A2AR AGONISTS |
US20090298834A1 (en) * | 2008-06-02 | 2009-12-03 | Hassan Pajouhesh | 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers |
JP4964854B2 (ja) | 2008-10-01 | 2012-07-04 | ハートウェア・インコーポレーテッド | 血栓形成阻止手段を備えたシールレス血液ポンプ |
-
2011
- 2011-09-28 KR KR1020110098310A patent/KR101803955B1/ko active IP Right Grant
- 2011-09-28 EP EP11829552.6A patent/EP2621899B1/en active Active
- 2011-09-28 CA CA2813189A patent/CA2813189C/en active Active
- 2011-09-28 US US13/876,803 patent/US8822463B2/en active Active
- 2011-09-28 JP JP2013531485A patent/JP5921555B2/ja active Active
- 2011-09-28 AU AU2011308174A patent/AU2011308174A1/en not_active Abandoned
- 2011-09-28 MX MX2013003389A patent/MX2013003389A/es not_active Application Discontinuation
- 2011-09-28 CN CN201180046849.7A patent/CN103237790B/zh active Active
- 2011-09-28 WO PCT/KR2011/007117 patent/WO2012044046A2/en active Application Filing
- 2011-09-28 BR BR112013005873A patent/BR112013005873A2/pt not_active Application Discontinuation
- 2011-09-28 RU RU2013114767/04A patent/RU2013114767A/ru not_active Application Discontinuation
- 2011-09-28 ES ES11829552.6T patent/ES2556460T3/es active Active
-
2013
- 2013-03-05 ZA ZA2013/01674A patent/ZA201301674B/en unknown
- 2013-03-27 CL CL2013000835A patent/CL2013000835A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP2621899B1 (en) | 2015-10-21 |
BR112013005873A2 (pt) | 2016-05-10 |
JP5921555B2 (ja) | 2016-05-24 |
CA2813189C (en) | 2020-04-28 |
WO2012044046A2 (en) | 2012-04-05 |
AU2011308174A1 (en) | 2013-03-21 |
RU2013114767A (ru) | 2014-11-10 |
EP2621899A4 (en) | 2014-03-26 |
KR101803955B1 (ko) | 2017-12-01 |
ZA201301674B (en) | 2014-05-28 |
KR20120033271A (ko) | 2012-04-06 |
CN103237790B (zh) | 2014-12-03 |
MX2013003389A (es) | 2013-06-24 |
WO2012044046A3 (en) | 2012-06-07 |
US20130217686A1 (en) | 2013-08-22 |
CN103237790A (zh) | 2013-08-07 |
JP2013538848A (ja) | 2013-10-17 |
EP2621899A2 (en) | 2013-08-07 |
CL2013000835A1 (es) | 2013-10-18 |
US8822463B2 (en) | 2014-09-02 |
CA2813189A1 (en) | 2012-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2599752T3 (es) | Método de producción de un derivado de 4, 4-difluoro-3,4-dihidroisoquinolina | |
ES2310787T3 (es) | Uso de 2-fluoro-3-cetoesteres para preparar 3-fluoro-6,7,8,9-tetrahidro-4h-pirimido(1,2-a)-pirimidin-4-onas. | |
ES2535534T3 (es) | Una síntesis exo-selectiva de los análogos de himbacina | |
EP3447051A1 (en) | Method for preparing tyrosine kinase inhibitor and derivative thereof | |
JP6420294B2 (ja) | イリジウム(iii)錯体 | |
US9505759B2 (en) | Pd-catalyzed coupling of pyrazole amides | |
ES2556460T3 (es) | Derivados novedosos de metilciclohexano y usos de los mismos | |
JP6174161B2 (ja) | 2−アミノニコチン酸ベンジルエステル誘導体の製造方法 | |
EP3498695B1 (en) | Method for synthesizing 3-(difluoromethyl)-1-methyl-1h-pyrazole-4-carboxylic acid | |
CN109608464B (zh) | 一种放射性碘标记Larotrectinib化合物及其制备方法和应用 | |
ES2594031T3 (es) | Derivados de ariletinilo | |
Han et al. | Synthesis and bioactivity of novel 3-(1-hydroxyethylidene)-5-substituted-pyrrolidine-2, 4-dione derivatives | |
Chen et al. | Asymmetric aza-Michael addition: synthesis of (−)-allosedridine and (−)-2-epi-ethylnorlobelol | |
CN103613602B (zh) | 藤黄酸衍生物及其制备方法和应用 | |
JP4152353B2 (ja) | 殺菌性ピリジン化合物 | |
Harish et al. | Enantiomerically pure piperazines via NaBH4/I2 reduction of cyclic amides | |
BR112021011084A2 (pt) | Processo para preparar 1-[(3r,4s)-4-cianotetrahidropiran-3-il]-3-[(2-fluoro-6-metoxi-4-piridil)amino]pirazol-4-carboxamida | |
KR20210029470A (ko) | 피리미딘일 바이피리딘 화합물의 제조방법 및 그를 위한 중간체 | |
Zhang et al. | Magnesium-promoted reductive acylation of aromatic conjugated ynones accompanying with transposition of the triple bond | |
CA2858778A1 (en) | Process for the preparation of 2-phenyl-[1,2,4]triazolo[1,5-a]pyridine derivatives | |
KR20060113922A (ko) | 살균성 피리딘 화합물의 제조방법 및 살균성 피리딘 화합물 | |
CN104356077B (zh) | 一类不对称酰基保护的2,5-二酮哌嗪衍生物及其制备方法和应用 | |
JP2016185993A (ja) | 1−ベンゾイル−5−オキソ−2,3,4,5−テトラヒドロ−1H−ベンゾ[b]アゼピン−4−カルボン酸エステルの製造方法 | |
Ma et al. | Photochemical studies on acyclic alkyl aromatic ketones in the solid state: asymmetric induction and increased chemoselectivity | |
JP4134290B2 (ja) | ポリフェノール誘導体、その製造方法、抗酸化剤、および発がん予防剤 |